About Us
History
| Year | Business Developments | Products |
|---|---|---|
| 2009 |
|
|
| 2008 |
|
|
| 2007 |
|
|
| 2006 |
|
|
| 2005 | Professional teams for clinical nutrition established nationwide. |
OS-1 launched nationwide.
|
| 2004 | Ichiro Otsuka appointed President. |
|
| 2003 | J.O. Pharma Co., Ltd. established. |
|
| 2002 |
|
|
| 2001 | Parenteral nutrition business of Welfide Corporation transferred to Otsuka. Toyama Factory established. | Intralipos launched (intravenous fat emulsion). |
| 1998 | Kyoichi Komatsu appointed President. The Otsuka Museum of Art founded to commemorate 75th anniversary of establishment of the Otsuka Group. |
|
| 1996 | Aminofluid (PPN solution containing glucose, amino acids, and electrolytes) and Kidmin (7.2% amino acid solution for renal failure) launched. | |
| 1995 | Otsuka multi-chamber bag system developed. | |
| 1994 | Yoshimitsu Otsuka appointed President. | Trifluid launched (PPN solution containing carbohydrates and electrolytes). Aminotripa launched (TPN solution containing carbohydrates, amino acids, and electrolytes). |
| 1990 | Matsushige Factory begins operations. | |
| 1988 | Amiparen launched (10% amino acid solution). | |
| 1986 | Akihiko Otsuka appointed President. | Triparen launched (TPN solution containing carbohydrates [GFX] and electrolytes). |
| 1985 | Otsuka Techno Corporation established. | |
| 1984 | Aminoleban launched (amino acid solution for hepatic encephalopathy). | |
| 1982 | Plas-Amino launched (glucose and amino acid solution). | |
| 1981 | China Otsuka Pharmaceutical Co., Ltd. (Tianjin) established. | |
| 1979 | Potacol-R launched (maltose and electrolyte solution). | |
| 1977 | Arab Otsuka Pharmaceutical Co., S.A.E. established. |
|
| 1976 | Kushiro Factory starts operations. |
|
| 1975 | Yoshimitsu Otsuka appointed President. |
|
| 1974 | PT Otsuka Indonesia established. |
Martos-10 launched (maltose solution). |
| 1972 |
|
|
| 1969 | Otsuka Pharmaceutical Factory becomes Otsuka Pharmaceutical Factory, Inc. Masahito Otsuka appointed President. |
Oronine Ointment changed to Oronine D Ointment. New plastic (polypropylene) bottle for IV solutions developed. |
| 1968 | Lactec Injection launched (lactated ringer’s solution). Plastic bottle (polyethylene) for IV solutions developed. |
|
| 1965 |
|
|
| 1964 | Separation of Sales Division of Otsuka Pharmaceutical Factory (excluding four prefectures in Shikoku region) and establishment of Otsuka Pharmaceutical Co., Ltd. |
|
| 1963 | KN Solutions launched (multiple electrolyte solutions). |
|
| 1953 | First over-the-counter drug launched: Oronine Ointment. |
|
| 1950 | Separation of Chemicals Division of Otsuka Pharmaceutical Factory and establishment of Otsuka Chemical Co., Ltd. |
|
| 1947 | Masahito Otsuka succeeds Busaburo Otsuka as company owner. |
|
| 1946 | Otsuka Pharmaceutical Factory starts production and distribution of intravenous solutions in accordance with the Japanese Pharmacopoeia. |
|
| 1935 | Otsuka Pharmaceutical renamed Otsuka Pharmaceutical Factory. |
|
| 1921 | Busaburo Otsuka founds “Otsuka Seiyaku Kogyobu” (Otsuka Pharmaceutical). |
Elneopa No. 1 Injection and Elneopa No. 2 Injection launched. Elneopa No. 1 Injection and Elneopa No. 2 Injection are total parenteral nutrition (TPN) solutions in quadruple-chamber bags.
HINE Jelly AQUA launched.
Inner Power launched.
ARTCEREB Irrigation and Perfusion Solution for Cerebrospinal Surgery launched.
Engelead Mini Apple Jelly, Engelead Mini Grape Jelly, and Engelead Mini Mint Flavor Jelly launched.
Large-volume packages of Neoparen No. 1 and Neoparen No. 2 (1500 mL and 2000 mL) launched. Neoparen No. 1 and No. 2 are total parenteral nutrition (TPN) solutions in triple-chamber bags. 
HINE Jelly concentrated liquid diet launched.
HINE concentrated liquid diet launched.
OS-1 Jelly approved as a food for special dietary uses and for persons with medical conditions.
Bfluid Injection launched (an amino acid and glucose injection with electrolytes and vitamin B1).
Engelead Apple Jelly launched (food for persons with difficulty chewing or swallowing).
ANOM concentrated liquid diet launched.
Urepearl Plus Gel20 launched
OS-1 approved as a food for special dietary uses and for persons with medical conditions.
Neoparen No. 1 and Neoparen No. 2 launched (TPN solutions containing glucose, amino acids, electrolytes, and vitamins).
Oronine Solution launched to commemorate the 50th anniversary of Oronine Ointment.
GFO launched.
Mixid-L and Mixid-H launched (TPN solutions containing glucose, amino acids, electrolytes, and lipid).
Oronine D Ointment changed to Oronine H Ointment.
Oronamin C Drink launched.
|
